In addition, 1,4-dihydroxy quininib reduced clonal formation and gene silencing of CysLT1R significantly reduced expression of angiogenic marker calpain-2, which further confirmed the importance of CysLT1R in cancer progression and angiogenesis [58]. This evidence concerns the gene CYSLTR1 and cancer.